Matinas BioPharma Holdings, Inc. (MTNB) Buy Target $0.93 – Sell Target $1.42

Trade Setup

Buy Target $0.93Sell Target 1 $1.22
Trailing Stop 20%Sell Target 2 $1.42

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company develops products using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals, which could encapsulate small molecules, gene therapies, vaccines, proteins, and peptides. The company’s lead product candidate is MAT9001, a prescription-only omega-3 free fatty acid formulation for the treatment of cardiovascular and metabolic conditions.